PET technology for drug development in psychiatry
PET technology for drug development in psychiatry
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Positron emission tomography (PET) is a non‐invasive imaging method to measure the molecule in vivo. PET imaging can evaluate the central nervous system drugs as target engagement in the human brain. For antipsychotic drugs, adequate dopamine D2 receptor occupancy (“therapeutic window”) is reported to be from 65%‐70% to 80% to achieve the antipsych...
Alternative Titles
Full title
PET technology for drug development in psychiatry
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_572320dcf5b84a2e9c3fc24c7a437004
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_572320dcf5b84a2e9c3fc24c7a437004
Other Identifiers
ISSN
2574-173X
E-ISSN
2574-173X
DOI
10.1002/npr2.12084
